Corporate Banner
Satellite Banner
Genotyping & Gene Expression
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Insight Genetics Promotes Four

Published: Wednesday, February 13, 2013
Last Updated: Wednesday, February 13, 2013
Bookmark and Share
Molecular diagnostics company builds expertise and depth in research, application and commercial development of companion diagnostics to improve cancer care.

Insight Genetics has announced that it has promoted four of its team members:
• Brock Schweitzer, PhD, is now senior scientist;
• Rachel Skelton, PhD, was promoted to regulatory scientist I;
• Kasey Lawrence was named technology specialist; and
• JonEric Pettersson assumed a new role as manager of commercial development.

Since its founding in 2007, Insight Genetics has been dedicated to enabling precision medicine in cancer care. The company collaborates with researchers, clinicians, and drug developers to develop molecular diagnostics that aid physicians in precisely typing and effectively treating patients’ cancers.

“Brock, Rachel, Kasey and JonEric have brought a breadth of knowledge and expertise to Insight Genetics that has helped us consistently generate exceptional scientific results and inform our business development efforts,” said Christopher Callaghan, president and COO of Insight Genetics. “They have all made significant contributions to our company’s growth and been integral in advancing the field of personalized cancer care.”

Senior Scientist Schweitzer, who completed his post-doctoral research training in immune cell function at Vanderbilt University School of Medicine, plans and conducts laboratory research on Insight Genetics’ expanding array of diagnostic tests.

He also contributes to the company’s licensing of biomarkers and technologies, and supports planning and coordination of its academic, clinical and corporate partnerships.

Before joining Insight Genetics as scientist II in 2012, Schweitzer received his PhD in molecular genetics from University of Cincinnati College of Medicine.

As regulatory scientist I, Skelton works with clinicians, researchers and pharmaceutical companies to test patient samples for cancer-causing biomarkers within Insight Genetics’ CLIA-certified molecular diagnostic lab.

She also ensures scientific and regulatory compliance for all tests performed in the lab. Skelton joined Insight Genetics in July 2012 after receiving her PhD in cell and developmental biology from Vanderbilt University School of Medicine, where she became proficient in molecular diagnostics and genetic screening.

As a technology specialist, Lawrence oversees day-to-day operations and conducts research for clinical tests in development, while also managing data in the CLIA lab.

As in his previous role as research associate III, Lawrence will continue to use his research background to apply new techniques and technologies in the company’s diagnostic lab.

Prior to joining Insight Genetics, Lawrence worked as a research assistant at Vanderbilt University’s Division of Genetic Medicine and the Genome Sciences Resource. He holds a bachelor of science in biology from Tennessee Tech University.

Pettersson, as manager of commercial development, guides commercialization of the company’s products for cancer diagnosis and monitoring. He also will identify new diagnostic and partnership opportunities for Insight Genetics.

Pettersson joined Insight Genetics in 2007 and became the company’s senior associate of business development in 2011.

He holds a bachelor’s degree in business administration, with a focus on international business, from Belmont University.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Genetic Mechanism Behind Cancer-Causing Mutations
Researchers at Indiana University has identified a genetic mechanism that is likely to drive mutations that can lead to cancer.
How to Unlock Inaccessible Genes
An international team of biologists has discovered how specialized enzymes remodel the extremely condensed genetic material in the nucleus of cells in order to control which genes can be used.
Viral Gene Editing System Corrects Genetic Liver Disease
Penn study has implications for developing safe therapies for an array of rare diseases via new gene cut-and-paste methods.
Mapping Regulatory Elements
Systematically searching DNA for regulatory elements indicates limits of previous thinking
New Biomarker to Assess Stem Cells Developed
A research team led by scientists from UCL have found a way to assess the viability of 'manufactured' stem cells known as induced pluripotent stem cells (iPSCs). The team's discovery offers a new way to fast-track screening methods used in stem cell research.
'Junk' DNA Plays Role in Preventing Breast Cancer
Supposed "junk" DNA, found in between genes, plays a role in suppressing cancer, according to new research by Universities of Bath and Cambridge.
Genome-Wide Study Yields Markers of Lithium Response
An international consortium of scientists has identified a stretch of chromosome that is associated with responsiveness to the mood-stabilizing medication lithium among patients with bipolar disorder.
A Cancer’s Surprise Origins, Caught in Action
First demonstration of a melanoma arising from a single cell.
Understanding the Mechanisms Blocking Cancer Cell Growth
DNA damage can lead to gene inactivation or deregulation and cause various diseases such as cancer; however, many DNA repair mechanisms allow cells to survive against such damage.
Faster Drug Discovery?
Startup develops more cost-effective test for assessing how cells respond to chemicals.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!